| Literature DB >> 28149104 |
Mehmet Onur Yüksel1, Mehmet Sabri Gürbüz2, Osman Tanrıverdi1, Sevilay Akalp Özmen3.
Abstract
Lipomatous meningiomas are extremely rare subtypes of benign meningiomas and are classified as metaplastic meningioma in the World Health Organization classification. We present a 77-year-old man presented with the history of a gradually intensifying headache for the last 3 months. A right frontoparietal mass was detected on his cranial magnetic resonance imaging. The patient was operated on via a right frontoparietal craniotomy, and histopathological diagnosis was lipomatous meningioma. Distinctive characteristics of lipomatous meningiomas were discussed with special emphasis to importance of immunohistochemical examinations, particularly for its differentiation from the tumors showing similar histology though having more aggressive character.Entities:
Keywords: Differential diagnosis; histopathological diagnosis; lipoblastic meningioma
Year: 2017 PMID: 28149104 PMCID: PMC5225703 DOI: 10.4103/0976-3147.193539
Source DB: PubMed Journal: J Neurosci Rural Pract ISSN: 0976-3155
Figure 1(a) Preoperative T1-weighted contrast-enhanced axial cranial magnetic resonance imaging showing a right frontoparietal mass lesion and perilesional edema. (b) Preoperative T1-weighted contrast-enhanced coronal cranial magnetic resonance imaging showing a right frontoparietal mass lesion and perilesional edema. (c) Preoperative T1-weighted contrast-enhanced sagittal cranial magnetic resonance imaging showing a right frontoparietal mass lesion and perilesional edema
Figure 2Postoperative axial cranial computed tomography image showing tumor removal with normal postoperative changes and persisting preexisting perilesional edema
Figure 3(a) Tumor tissue containing large cells seeming as fat-like proliferation with classic meningothelial neoplastic cells. Tumor cells have round nuclei and fat vacuoles in their cytoplasms (H and E, ×40). (b) Tumor tissue showing the expression of epithelial membrane antigen (EMA, ×40). (c) Tumor tissue showing positive staining with vimentin (Vimentin, ×40). (d) Tumor tissue showing the expression of progesterone receptor (PR, ×200)